Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$420.05
-0.7%
$398.72
$289.36
$425.35
$136.32B1.432.39 million shs1.97 million shs
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$146.82
-1.2%
$155.69
$143.13
$175.97
$353.80B0.537.39 million shs7.63 million shs
The 10 Best AI Stocks to Own in 2024 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
-0.16%+4.74%+4.47%+10.54%+24.61%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
-0.69%+2.60%-4.31%-6.94%-10.08%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
4.6408 of 5 stars
2.44.02.53.02.52.52.5
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
4.9084 of 5 stars
3.23.04.23.93.02.51.9

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
2.75
Moderate Buy$434.933.54% Upside
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
2.46
Hold$175.8619.78% Upside

Current Analyst Ratings

Latest JNJ and GS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/18/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$169.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetEqual Weight ➝ Equal Weight$168.00 ➝ $167.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$180.00 ➝ $170.00
4/17/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetOutperform ➝ Outperform$181.00 ➝ $175.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetBuy ➝ Buy$460.00 ➝ $470.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetMarket Perform ➝ Market Perform$349.00 ➝ $360.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetNeutral ➝ Neutral$410.00 ➝ $425.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Evercore ISI
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$435.00 ➝ $440.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetSector Perform ➝ Sector Perform$390.00 ➝ $405.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOverweight ➝ Overweight$424.00 ➝ $433.00
4/16/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$446.00 ➝ $479.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$108.42B1.26$40.62 per share10.34$363.61 per share1.16
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$85.16B4.15$13.42 per share10.94$28.57 per share5.14

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.52B$25.6116.4010.831.368.17%8.65%0.58%7/17/2024 (Estimated)
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$35.15B$16.049.1513.412.4645.26%36.43%15.01%7/18/2024 (Estimated)

Latest JNJ and GS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/16/2024Q1 24
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$2.64$2.71+$0.07$3.22$21.39 billion$21.38 billion    
4/15/2024Q1 2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$8.54$11.58+$3.04$11.58$12.94 billion$14.21 billion    

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
$11.002.62%+28.06%42.95%3 Years
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
$4.763.24%+5.70%29.68%63 Years

Latest JNJ and GS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/11/2024
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
Quarterly$2.752.77%5/30/20245/30/20246/27/2024
4/16/2024
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
quarterly$1.243.36%5/20/20245/21/20246/4/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
1.98
1.12
0.76
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.38
1.16
0.91

Ownership

Institutional Ownership

CompanyInstitutional Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
71.21%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
69.55%

Insider Ownership

CompanyInsider Ownership
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
0.54%
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
0.16%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
The Goldman Sachs Group, Inc. stock logo
GS
The Goldman Sachs Group
45,300324.53 million322.78 millionOptionable
Johnson & Johnson stock logo
JNJ
Johnson & Johnson
131,9002.41 billion2.41 billionOptionable

JNJ and GS Headlines

SourceHeadline
LLY vs. JNJ: Which Big Pharma Stock Is Better?LLY vs. JNJ: Which Big Pharma Stock Is Better?
msn.com - April 25 at 11:47 AM
Johnson & Johnsons (NYSE:JNJ) Dividend Will Be Increased To $1.24Johnson & Johnson's (NYSE:JNJ) Dividend Will Be Increased To $1.24
finance.yahoo.com - April 25 at 11:47 AM
Johnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by Cornerstone Investment Partners LLCJohnson & Johnson (NYSE:JNJ) Stock Holdings Lessened by Cornerstone Investment Partners LLC
marketbeat.com - April 25 at 5:42 AM
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6%Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.6%
marketbeat.com - April 24 at 4:21 PM
Vanda (VNDA) to Report Q1 Earnings: Whats in the Cards?Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
finance.yahoo.com - April 24 at 3:27 PM
PBIRx Growth Fueled by Johnson & Johnson ERISA LawsuitPBIRx Growth Fueled by Johnson & Johnson ERISA Lawsuit
businesswire.com - April 24 at 2:35 PM
The Top 7 Dividend Stocks to Buy in 2024 to Build Lasting WealthThe Top 7 Dividend Stocks to Buy in 2024 to Build Lasting Wealth
investorplace.com - April 24 at 7:25 AM
Johnson & Johnson (NYSE:JNJ) Shares Bought by Ninety One UK LtdJohnson & Johnson (NYSE:JNJ) Shares Bought by Ninety One UK Ltd
marketbeat.com - April 24 at 5:44 AM
Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold ForeverGot $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever
fool.com - April 24 at 5:25 AM
Johnson & Johnson Childrens Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)Johnson & Johnson Children's Cough Syrup Contaminated In Some Batches - WHO Poised to Issue Global Alert (Updated)
msn.com - April 24 at 4:42 AM
Johnson and Johnson (JNJ) Elliott Wave technical analysis [Video]Johnson and Johnson (JNJ) Elliott Wave technical analysis [Video]
fxstreet.com - April 24 at 4:42 AM
Warning! These 3 Blue-Chip Stocks Will Have You Seeing RedWarning! These 3 Blue-Chip Stocks Will Have You Seeing Red
investorplace.com - April 23 at 4:30 PM
Johnson & Johnson (NYSE:JNJ) Trading Down 0.1%Johnson & Johnson (NYSE:JNJ) Trading Down 0.1%
marketbeat.com - April 23 at 2:58 PM
4 Stocks to Watch on Their Recent Dividend Hikes4 Stocks to Watch on Their Recent Dividend Hikes
zacks.com - April 23 at 9:46 AM
Johnson & Johnson (NYSE:JNJ) Shares Purchased by Migdal Insurance & Financial Holdings Ltd.Johnson & Johnson (NYSE:JNJ) Shares Purchased by Migdal Insurance & Financial Holdings Ltd.
marketbeat.com - April 23 at 5:27 AM
Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)Johnson & Johnson Sees Unusually High Options Volume (NYSE:JNJ)
americanbankingnews.com - April 23 at 1:06 AM
Johnson & Johnson Sees Unusually Large Options Volume (NYSE:JNJ)Johnson & Johnson Sees Unusually Large Options Volume (NYSE:JNJ)
marketbeat.com - April 22 at 5:58 PM
Johnson & Johnson to Participate in the Bernsteins 40th Annual Strategic Decisions Conference (SDC)Johnson & Johnson to Participate in the Bernstein's 40th Annual Strategic Decisions Conference (SDC)
businesswire.com - April 22 at 4:30 PM
Johnson & Johnson: Legal Woes Are Detrimental But Not FatalJohnson & Johnson: Legal Woes Are Detrimental But Not Fatal
seekingalpha.com - April 22 at 3:55 PM
Johnson & Johnson (NYSE:JNJ) Shares Up 0.8%Johnson & Johnson (NYSE:JNJ) Shares Up 0.8%
marketbeat.com - April 22 at 1:54 PM
Johnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on ItJohnson & Johnson (JNJ) Is a Trending Stock: Facts to Know Before Betting on It
zacks.com - April 22 at 10:05 AM
Saybrook Capital NC Has $8.32 Million Position in Johnson & Johnson (NYSE:JNJ)Saybrook Capital NC Has $8.32 Million Position in Johnson & Johnson (NYSE:JNJ)
marketbeat.com - April 22 at 5:47 AM
Johnson & Johnson (NYSE:JNJ) Shares Sold by Mackenzie Financial CorpJohnson & Johnson (NYSE:JNJ) Shares Sold by Mackenzie Financial Corp
marketbeat.com - April 21 at 5:34 AM
Johnson & Johnson (NYSE:JNJ) Trading Up 0.4%Johnson & Johnson (NYSE:JNJ) Trading Up 0.4%
americanbankingnews.com - April 21 at 3:14 AM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

All Headlines

Company Descriptions

The Goldman Sachs Group logo

The Goldman Sachs Group

NYSE:GS
The Goldman Sachs Group, Inc., a financial institution, provides a range of financial services for corporations, financial institutions, governments, and individuals worldwide. It operates through Global Banking & Markets, Asset & Wealth Management, and Platform Solutions segments. The Global Banking & Markets segment provides financial advisory services, including strategic advisory assignments related to mergers and acquisitions, divestitures, corporate defense activities, restructurings, and spin-offs; and relationship lending, and acquisition financing, as well as secured lending, through structured credit and asset-backed lending and involved in financing under securities to resale agreements. This segment also offers client execution activities for cash and derivative instruments; credit and interest rate products; and provision of mortgages, currencies, commodities, and equities related products, as well as underwriting services. The Asset & Wealth Management segment manages assets across various classes, including equity, fixed income, hedge funds, credit funds, private equity, real estate, currencies, and commodities; and provides customized investment advisory solutions, wealth advisory services, personalized financial planning, and private banking services, as well as invests in corporate equity, credit, real estate, and infrastructure assets. The Platform Solutions segment offers credit cards and point-of-sale financing for purchase of goods or services. This segment also provides cash management services, such as deposit-taking and payment solutions for corporate and institutional clients. The Goldman Sachs Group, Inc. was founded in 1869 and is headquartered in New York, New York.
Johnson & Johnson logo

Johnson & Johnson

NYSE:JNJ
Johnson & Johnson, together with its subsidiaries, researches, develops, manufactures, and sells various products in the healthcare field worldwide. The company's Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. Its MedTech segment provides Interventional Solutions, including electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; and neurovascular care that treats hemorrhagic and ischemic stroke. this segment also offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics, ear, nose, and throat procedures; contact lenses under the ACUVUE Brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. Johnson & Johnson was founded in 1886 and is based in New Brunswick, New Jersey.